Prediction of Clinically Significant Prostate Cancer by a Specific Collagen-related Transcriptome, Proteome, and Urinome Signature
Article in European Urology Oncology (June 2024)
The most recent citing publications are shown below. View all 152 publications that cite this research output on Dimensions.
A phase II study (AARDVARC) of AZD4635 in combination with durvalumab and cabazitaxel in patients with progressive, metastatic, castration-resistant prostate cancer
Article in ESMO Open (June 2024)
Failed Induction of the TH1 System in TH2 Dominant Patients: The Cancer-Permissive Immune Macroenvironment.
Article in Integrative Medicine (May 2024)